This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Johns Hopkins University, Lieber Institute, Inc.. Active years: 2026.
Company Filing History:
1 out of 3,790 
1 out of 9 
Years Active: 2026
Title: Asma Begum: Innovator in RNA Polymerase Inhibition
Introduction
Asma Begum is a notable inventor based in Baltimore, MD (US). She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit RNA polymerase. Her work has implications for treating various diseases, including cancer.
Latest Patents
Asma Begum holds 1 patent for her invention titled "Compounds which inhibit RNA polymerase." This patent discloses chemical entities, including compounds and their pharmaceutically acceptable salts, that inhibit RNA polymerase I (Pol I). These chemical entities are particularly useful for treating conditions where excessive Pol I activity contributes to disease pathology, symptoms, or progression.
Career Highlights
Throughout her career, Asma has worked with prestigious institutions, including Johns Hopkins University and the Lieber Institute, Inc. Her research has focused on the therapeutic potential of her inventions in addressing serious health conditions.
Collaborations
Asma has collaborated with various professionals in her field, including her coworker Hester Hui Liu, who has also contributed to advancements in biochemistry.
Conclusion
Asma Begum's innovative work in RNA polymerase inhibition showcases her dedication to advancing medical science and improving treatment options for patients. Her contributions are a testament to the impact of research and innovation in healthcare.